Abbott Laboratories News

This is shaping up as the worst year for dividend cuts in three generations. Striving to conserve cash amid the most severe slump since the Depression, companies are reducing or eliminating their payouts to shareholders.

In 2001, Lillie Greene's life was turned upside down. Her son, not knowing he was diabetic, suffered an aneurysm and went into a coma for 32 days.

Abbott Laboratories this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat bipolar disorder and epilepsy, are under federal investigation.

Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnsona s Centocor unit in a suit over an arthritis drug patent.

Think about your favorite company, the one you believe in the most. Now imagine getting its logo tattooed on your biceps.

NATICK, Mass. - Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.

It took six months from when shareholders asked for it , but Pfizer 's board has finally given shareholders a voice on executive compensation.

Abbott announced today that it has received the annual Illinois Continuous Improvement Award for environmental excellence.

Impax Laboratories Inc. confirmed Friday it is challenging the patents on Abbott Laboratories' cholesterol drug TriCor, and that Abbott is suing Impax for patent infringement.

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICORA tablets, 48 mg and 145 mg.

Main Category: Eczema / Psoriasis Also Included In: Dermatology Article Date: 29 Oct 2009 - 2:00 PDT Findings from a national survey Psoriasis Uncovered, show that for those with the most severe1 form of the condition, psoriasis has an irreversible effect on one in two patients' lives.1 Launching on World Psoriasis Day, the results of the survey ...

Rob McIver, co-manager of the Jensen Fund , says long-term investing success means selecting high-quality securities, such as Abbott Laboratories and Adobe .

Chicago may have lost out on the 2016 Olympics, but it still hosts an annual competition in innovation.

If recent events are any clue, M&A activity appears to be heating up on Wall Street.

Abbott, a global health care company today celebrated the dedication of its new Abbott Nutrition facility at the Research Park on the University of Illinois campus.

Just when it looked like Amgen was turning things around a whack! The Food and Drug Administration has thrown a wrench in the biotech's plans.

Eli Lilly & Co. said Wednesday it turned a profit in the third quarter as a legal costs came off its books, and the drugmaker raised its forecasts for the year.

Pfizer Inc. on Tuesday posted a higher third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales.

When Pfizer releases earnings on the other side of the sunrise, we'll get a last look at the company pre-Wyeth . Here's what you can expect from the pharmaceutical giant.

Global pharmaceutical companies Baxter International Incorporated : and Abbott Laboratories : this week reported earnings for the third quarter of their 2009 fiscal years.